🇺🇸 FDA

Company profile · Sponsor

Second

Second Affiliated Hospital, School of Medicine, Zhejiang University

CC9504B · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Second (CC9504B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CC9504B
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. 3-N-butylphthalide

    Second

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  2. Inhaled corticosteriod/long-acting beta-agonist plus Montelukast

    Second

    Asthma

    small molecule active

    1 trial

Frequently asked questions

What is Second?

Second (CC9504B) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Second sponsor?

We track 2 ClinicalTrials.gov-linked programs for Second, including 3-N-butylphthalide and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Second company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.